Diferencia entre revisiones de «Template:Meningitis Antibiotics»

Sin resumen de edición
Sin resumen de edición
Línea 36: Línea 36:
===Age >50y===
===Age >50y===
*[[Ceftriaxone]] 2gm IV q12hr + [[Vancomycin]] 15mg/kg q8-12hr + [[Ampicillin]] 2gm IV q4h
*[[Ceftriaxone]] 2gm IV q12hr + [[Vancomycin]] 15mg/kg q8-12hr + [[Ampicillin]] 2gm IV q4h


<references/>
<references/>

Revisión del 21:58 19 jun 2015

Treatment guidelines based on van de Beek et al[1]

Neonates (up to 1 month of age)

MRSA is uncommon in the neonate

  • Ampicillin 75mg/kg IV q6hrs PLUS
  • Cefotaxime 50mg/kg IV q6hrs OR 2.5mg/kg IV q8hrs
    • Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups[2]
  • If suspecting S. pneumoniae or MRSA, add standard neonatal dosing
  • Consider acyclovir for HSV

> 1 month to Adult

> 50 yoa

  • Ceftriaxone 2gm (50mg/kg) IV BID daily PLUS
  • Vancomycin 15-20 mg/kg IV BID daily PLUS
  • Ampicillin 2 g q4h (hourly if listeria suspected)[3]

Post Procedural (or penetrating trauma)


Cryptococcosis Meningitis

Options

  • Amphotericin B 1mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily
  • Amphotericin B 5mg/kg IV once daily AND Flucytosine 25mg/kg PO q6hrs daily


Neisseria meningitidis Prophylaxis

  • Ceftriaxone 250mg IM once (if less than 15yr then 125mg IM)
  • Ciprofloxacin 500mg PO once
  • Rifampin 600 mg PO BID x 2 days
    • if < 1 month old then 5mg/kg PO BID x 2 days
    • if ≥ 1 month old then 10mg/kg (max at 600mg) PO BID x 2 days

Meningitis with severe PCN allergy

Age >50y



  1. van de Beek D. et al. Advances in treatment of bacterial meningitis. Lancet. Nov 10 2012;380(9854):1693-702
  2. https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1
  3. [Guideline] Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul. 15(7):649-59.